Funding

Expansion Patent and SBIR Grants Awarded for Stem Cell Expansion Ex Vivo

Published in Blood Weekly, July 28th, 1997

CellPro, Inc., Seattle, Washington, announced that it has been granted a U.S. patent covering methods of ex vivo expansion of hematopoietic precursor, or stem, cells.

Ex vivo expansion of stem cells is important for a number of clinical applications, including retroviral-mediated gene transfer for use in certain gene therapy applications and the production of antigen-presenting dendritic cells, which are under study for use as anti-cancer vaccines.

CellPro's Ceprate SC Stem Cell Concentration System has been incorporated into over 20 clinical gene therapy protocols and the company expects to begin Phase I/II clinical studies of anti-cancer dendritic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1997-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry